Results 81 to 90 of about 25,478 (302)

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Domain Name: Digital Asset, Identifier, or Some Other Kind of Object?

open access: yesЦифровое право
This article is dedicated to a comprehensive analysis of the legal nature of a domain name as a special object functioning in the digital environment and proactively involved in civil commerce.
I. E. Titov, E. V. Alymova
doaj   +1 more source

Volume 5: Marks 1484-1887, June 1931-September 1934; Index

open access: yes, 1931
Series 401 | Secretary of State | Trademarks registers | Marks 1484-1887, June 1931-September 1934; IndexThis series is a chronological list of the trademarks filed with the Secretary of State.
Secretary of State
core  

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Trademark activity and the market performance of U.S. commercial banks

open access: yesJournal of Business Economics and Management, 2012
This empirical paper analyzes the effect of trademark activity on the market value and performance of US commercial banks from two perspectives. First, a longterm perspective considers the effect of such activity on banks’ Tobin's q. Second, with a short-
Carlos González-Pedraz   +1 more
doaj   +1 more source

PTDL Resources and Services at Georgia Tech Library

open access: yes, 2010
Patents and Trademarks 101. Workshop on patents and trademarks Sponsored by the Georgia Tech Library and USPTO.Handout for workshop program presented on November 3, 2010 from 9:00am - 4:30pm in the Georgia Tech Student Center ...

core  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Volume 4: Marks 1126-1483, September 1928-June 1931; Index

open access: yes, 1928
Series 401 | Secretary of State | Trademarks registers | Marks 1126-1483, September 1928-June 1931; IndexThis series is a chronological list of the trademarks filed with the Secretary of State.
Secretary of State
core  

The Economics of Trademarks [PDF]

open access: yes, 2015
There is extensive literature in several areas of academic study (marketing, international business, law, business finance, etc.) regarding brand names and trademarks. Different fields of study have analyzed the nature, applications and effects of brands
Ramos, Jorge Victor, Ramos, Jorge V.
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy